New personal care guidelines from the American Gastroenterological Association (AGA) and Gastroenterology Referral Center (GRC) have been released and have certain recommendations in in relation to treatment for colon polyps.

Colon polyps is a common problem in patients with diabetes mellitus and other chronic conditions. Polyps can affect almost any organ system including the stomach kidneys liver pancreas or gallbladder. More than 90 percent of patients will never overcome the infection and the colon polyp should be treated as soon as possible by diet a colonoscopy andor colonoscopy.

Colon polyps can be inherited from parents or from people with certain genetic or behavioral issues. Most people with the common type colon polyp develop diarrhea bloody diarrhea abdominal pain indigestion bleeding gums illness andor death due to the infection.

The Type 2 diabetes Mellitus (T2DM) and Gastrointestinal Dysfunction (Gud) can cause a lethal colon cancer. Gud involves a thin tissue that allows for extra organic tissue to fill the space of the colon. Weaker blood vessels in the colon lining and frequent recurring bowel obstruction are the major reasons for unwanted growth. Gastrointestinal dysfunction is often the chronic form. In patients with the accelerated diagnosis of unrecognized pre-cancerous polyps and who have the advanced stage of Gud surgical treatment is required because of the neurological side effects.

The lead guidelines from the American Gastroenterological Association (AGA) and the Gastroenterological Referral Center (GRC) have been published online by Gastroenterology in its journal CMAJ.

Some individual recommendations regarding treatment and management of colon polyps include:

Treat the patient with an activated antibody specific to polyps this is commonly used to treat HIV TB and E.coli infection among others. Test for anti-PD-1 antibodies which recognize the presence of harmful immune-trauma proteins on the colon tissue of the colon and that are released by colon cells when colon cells break down or digest other antigens. Immunosuppression therapies like immune checkpoint inhibitors are approved by the Food and Drug Administration and are used for certain acute andor chronic diseases.